Topics and Expertise: pharmacogenetics

The UCSF Asthma Collaboratory celebrates 20 years of research on genetic factors in asthma.

Vice Provost-Academic Affairs

My clinical practice and research focus on the drug treatment of epilepsy and the genetic, behavioral, and environmental factors that influence drug response.

Allopurinol, the first-choice medication for treating gout—an excruciatingly painful condition that is the most common form of inflammatory arthritis, afflicts more than eight million Americans, and is on the rise worldwide—is not fully effective in more than half of patients.

The most comprehensive genetic study of the Mexican population to date has revealed as much genetic differentiation as the variation between some Europeans and Asians.

Pharmacogenetics expert Kathy Giacomini, PhD, co-chair of the UCSF Department of Bioengineering and Therapeutic Sciences, is leading the UCSF arm of a research partnership in which her team will profile 2,000 prescription drugs against key molecules in the liver and kidney that are responsible for...